Cutler Investment Counsel LLC Bristol Myers Squibb CO Transaction History

Cutler Investment Counsel LLC

$733 Million
Q2 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	SELL	$63.71 - $70.74 $273,698 - $303,899	-4,296 Reduced 2.64%	158,363 $10.1 Million
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $55,196 - $62,605	840 Added 0.52%	162,659 $11.3 Million
Q4 2022 Jan 26, 2023	SELL	$68.48 - $81.09 $397,868 - $471,132	-5,810 Reduced 3.47%	161,819 $0
Q3 2022 Nov 07, 2022	SELL	$0.13 - $76.84 $64 - $38,189	-497 Reduced 0.3%	167,629 $11.9 Million
Q2 2022 Jul 19, 2022	BUY	$72.62 - $79.98 $134,274 - $147,883	1,849 Added 1.11%	168,126 $13 Million
Q1 2022 May 10, 2022	BUY	$61.48 - $73.72 $304,264 - $364,840	4,949 Added 3.07%	166,277 $12.1 Million
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $139,438 - $162,552	2,600 Added 1.64%	161,328 $10.1 Million
Q3 2021 Oct 15, 2021	BUY	$59.17 - $69.31 $65,146 - $76,310	1,101 Added 0.7%	158,728 $9.39 Million
Q2 2021 Aug 10, 2021	BUY	$61.91 - $67.42 $38,693 - $42,137	625 Added 0.4%	157,627 $10.5 Million
Q1 2021 May 07, 2021	BUY	$59.34 - $66.74 $64,146 - $72,145	1,081 Added 0.69%	157,002 $9.91 Million
Q4 2020 Jan 25, 2021	SELL	$57.74 - $65.43 $27,888 - $31,602	-483 Reduced 0.31%	155,921 $9.67 Million
Q3 2020 Oct 15, 2020	BUY	$57.43 - $63.64 $22,397 - $24,819	390 Added 0.25%	156,404 $9.43 Million
Q2 2020 Aug 19, 2020	SELL	$54.82 - $64.09 $110,571 - $129,269	-2,017 Reduced 1.28%	156,014 $9.17 Million
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $37,259 - $54,146	-803 Reduced 0.51%	158,031 $8.81 Million
Q4 2019 Feb 12, 2020	SELL	$49.21 - $64.19 $1.21 Million - $1.58 Million	-24,601 Reduced 13.41%	158,834 $10.2 Million
Q3 2019 Nov 15, 2019	BUY	$42.77 - $50.71 $1.59 Million - $1.88 Million	37,150 Added 25.4%	183,435 $9.3 Million
Q2 2019 Aug 05, 2019	SELL	$44.62 - $49.34 $26,370 - $29,159	-591 Reduced 0.4%	146,285 $6.63 Million
Q1 2019 May 07, 2019	BUY	$45.12 - $53.8 $147,316 - $175,657	3,265 Added 2.27%	146,876 $7.01 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $186,263 - $241,538	-3,820 Reduced 2.59%	143,611 $7.47 Million
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $69,097 - $77,937	1,252 Added 0.86%	147,431 $9.15 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $98,381 - $122,622	-1,947 Reduced 1.31%	146,179 $8.09 Million
Q1 2018 May 01, 2018	BUY	$59.92 - $68.98 $22,889 - $26,350	382 Added 0.26%	148,126 $9.37 Million
Q4 2017 Feb 13, 2018	BUY	$59.94 - $65.35 $81,698 - $89,072	1,363 Added 0.93%	147,744 $9.05 Million
Q3 2017 Nov 08, 2017	BUY	$55.23 - $63.74 $169,114 - $195,171	3,062 Added 2.14%	146,381 $9.33 Million
Q2 2017 Aug 14, 2017	BUY	N/A	143,319	143,319 $7.99 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Investment Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Investment Counsel LLC with notifications on news.

Account